VEVCX
Price
$49.74
Change
+$0.16 (+0.32%)
Updated
Nov 4 closing price
VMVIX
Price
$65.12
Change
+$0.03 (+0.05%)
Updated
Nov 4 closing price
Ad is loading...

VEVCX vs VMVIX

Header iconVEVCX vs VMVIX Comparison
Open Charts VEVCX vs VMVIXBanner chart's image
Victory Sycamore Established Value C
Price$49.74
Change+$0.16 (+0.32%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Investor
Price$65.12
Change+$0.03 (+0.05%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
VEVCX vs VMVIX Comparison Chart
Loading...
VS
VEVCX vs. VMVIX commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VEVCX is a Sell and VMVIX is a Sell.

FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 31.2B vs. VEVCX (18.8B). VMVIX pays higher dividends than VEVCX: VMVIX (2.03) vs VEVCX (0.38). VEVCX was incepted earlier than VMVIX: VEVCX (9 years) vs VMVIX (18 years). VEVCX is a more actively managed with annual turnover of: 28.00 vs. VMVIX (22.00). VEVCX has a lower initial minimum investment than VMVIX: VEVCX (2500) vs VMVIX (3000). VMVIX annual gain was more profitable for investors over the last year : 25.57 vs. VEVCX (16.04). VMVIX return over 5 years is better than : 44.55 vs. VEVCX (27.13).
VEVCXVMVIXVEVCX / VMVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years18 years-
Gain YTD10.52014.31373%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets18.8B31.2B60%
Annual Yield % from dividends0.382.0319%
Returns for 1 year16.0425.5763%
Returns for 3 years-2.4211.61-21%
Returns for 5 years27.1344.5561%
Returns for 10 years96.2793.19103%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LAUR17.300.40
+2.37%
Laureate Education
BXP80.331.17
+1.48%
BXP Inc.
TTI3.26-0.02
-0.61%
TETRA Technologies
ANIX3.47-0.19
-5.19%
Anixa Biosciences
KTTA3.60-0.20
-5.26%
Pasithea Therapeutics Corp